(Date:12/3/2009)... Shire plc (LSE: SHP, Nasdaq: SHPGY ), ... recall of five lots and voluntary market withdrawal of ... ® . Shire is taking this action because some ... may not meet their release liner removal specification, and ...
(Date:12/3/2009)... 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief ... http://www.beikebiotech.com ), spoke at a conference on ... 22, 2009. Beike is China,s leading,stem cell research ... The conference, organized by the Indian Podiatry ...
(Date:12/2/2009)... Reportlinker.com announces that a new market research ... Carbondioxide Incubators - A Global Market ... ,, Incubators are the most critical equipment ... other applications for providing a controlled environment ...
(Date:12/2/2009)... 2 Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM ) ... confirmation and dosimetry trial of Cotara® in patients with ... cancer. Cotara is a targeted monoclonal antibody linked ... treatment for GBM. Cotara specifically targets cells at ...
Breaking Biology Technology:Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 2Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 3Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 4Non-safety-related voluntary recall of a limited portion of Daytrana(R) (methylphenidate transdermal system) patches announced 5Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5... Epeius Biotechnologies,Corporation today announced that Rexin-G has ... and Drug Administration (FDA) for the,treatment of all ... third,clinical indication for which Rexin-G has been formally ... latest approval for Rexin-G validates the,company,s remarkable strategy ...
... 8, 2008Biotech and pharmaceutical firms are developing a ... complicated drug discovery process, reports Genetic Engineering ... successful approaches rely on a combination of high-throughput ... according to an article in the July issue ...
... in nanoscale lithographic technology, used in the manufacture of ... patterns of lines over larger areas than have been ... could pave the way for next-generation computer memory and ... other devices. , The team has created lines about ...
Other Biology Technology:FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas 2FDA Grants Epeius Biotechnologies' Rexin-G a Third Orphan Drug Designation, This Time for the Treatment of Soft Tissue Sarcomas 3MIT reports finer lines for microchips 214-3-3 tau Antibody Shipping Temperature: HOT Storage Temperature: -20C...
... Rabbit polyclonal to ThPok ( Abpromise ... Synthetic peptide conjugated to KLH derived from ... ThPok. (Note: the amino acid sequence is ... ab23412 .) Entrez Gene ID: ...
Anti 7H6 Antigen (tight-junction associated protein Antigen) Monoclonal Antibody 7H6...
...
Biology Products: